Blood News and Research

RSS

Clinical trials for diabetes drugs should measure outcomes important to patients

Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient's quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.

27 Sep 2007

Tumor cell receptor provides new therapeutic target

Working with a line of highly metastatic head and neck cancer cells, a research team at the Winship Cancer Institute and Emory University School of Medicine has found that a specific cell surface receptor present at very low levels in non-metastatic head and neck cancer cells.

27 Sep 2007

MicroPET-based biodistribution of quantum dots in living mice

A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.

27 Sep 2007

Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery

In the quest to turn carbon nanotubes from nanoscale wonder into clinically useful drug and imaging agent delivery agents, researchers have often added polymer coatings to the outside of the nanotubes in order to render them biocompatible.

27 Sep 2007

Researchers uncover likely source of rejection for otherwise well-matched kidney transplants

UT Southwestern Medical Center researchers, collaborating with colleagues in Germany, have for the first time identified antibodies associated with transplant rejection of otherwise healthy kidneys.

27 Sep 2007

UCLA Medical Center performs its first living donor kidney swap

UCLA Medical Center on Sept. 20 performed its first living donor kidney “swap,” a procedure in which a loved one of a kidney transplant patient who is not compatible as a donor exchanges organs with another incompatible pair under an innovative new paired donation program.

27 Sep 2007

Sandia develops portable microfluidic platform to detect biotoxins

Of all the threat scenarios facing emergency responders around the country, the release and spread of a dangerous biotoxin in a large public space is one of the most troubling.

27 Sep 2007

New molecular target in blood clot formation

Researchers at the University of Illinois at Chicago College of Medicine have identified a new molecular target in blood clot formation, which seems to reduce clotting without excessive bleeding, the common side-effect of anti-clotting agents.

27 Sep 2007

New research on glycemic index

In work investigating the reproducibility of glycemic index values, researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (USDA HNRCA) have reported that multiple glycemic index value determinations (measure of the rate of glucose absorption into the bloodstream) using a simple test food, white bread, resulted in a relatively high level of inter-individual (among different individuals), and intra-individual (within the same individual) variability.

27 Sep 2007

FDA warning on use of Fentora (fentanyl buccal)

The Food and Drug Administration is alerting health care professionals and consumers to concerns over the use of Fentora (fentanyl buccal) tablets after recent reports of deaths and other adverse events.

27 Sep 2007

Axitinib shows promise for patients with advanced kidney cancer

Barcelona, Spain: A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.

27 Sep 2007

Enzyme's second messenger contributes to cell overgrowth

Scientists at the University of California, San Diego (UCSD) School of Medicine have uncovered a novel pathway by which hormones elevated in inflammation, cancer and cell injury act on cells to stimulate their growth.

27 Sep 2007

Snake venom composition may change according to the victim

A snake's intended prey might affect the type and evolution of toxins in their venom, research published in the online open access journal BMC Evolutionary Biology shows.

27 Sep 2007

Coca-Cola accused of flase claims on Fuze drinks

To hear Coca-Cola tell it, the tea and fruit drinks it sells under its Fuze brand will help you avoid cancer, heart disease, colds, flu, and infections of the lungs and kidneys.

27 Sep 2007

All alcohol consumption linked to breast cancer risk

One of the largest individual studies of the effects of alcohol on the risk of breast cancer shows that it makes no difference whether a woman drinks wine, beer or spirits (liquor).

27 Sep 2007

Warning about dangerous potential of pain drug Fentora

The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.

26 Sep 2007

Scots second only to Americans when it comes to obesity

Health officials in Britain say Scotland now has the one of highest obesity rates in the developed world, and comes second to the United States.

26 Sep 2007

Under-used colon cancer screening test is effective

An under-used colon cancer screening test now available in the U.S. effectively detects colorectal cancer and may help to improve colon cancer screening rates, according to investigators at the Kaiser Permanente Division of Research.

26 Sep 2007

Biologists link Huntington's disease to health benefits in young

For years researchers in neurology have believed that people with Huntington's disease have more children than the general population because of behavioral changes associated with the disease that lead to sexual promiscuity.

26 Sep 2007

Effectiveness of interventions to promote screening for diabetic retinopathy

Increasing patient and clinician awareness and improving access to health care can encourage people with diabetes to seek annual eye exams, which help prevent a serious complication called retinopathy, according to a new systematic review of studies.

26 Sep 2007